Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-12.96%
operating margin TTM
-7.32%
revenue TTM
1.91 Billion
revenue per share TTM
14.55$
valuation ratios | |
|---|---|
| pe ratio | -185.69 |
| peg ratio | 10.21 |
| price to book ratio | 236.45 |
| price to sales ratio | 24.33 |
| enterprise value multiple | -349.33 |
| price fair value | 236.45 |
profitability ratios | |
|---|---|
| gross profit margin | 83.64% |
| operating profit margin | -7.32% |
| pretax profit margin | -15.42% |
| net profit margin | -12.96% |
| return on assets | -6.99% |
| return on equity | -274.21% |
| return on capital employed | -5.52% |
liquidity ratios | |
|---|---|
| current ratio | 2.80 |
| quick ratio | 2.75 |
| cash ratio | 0.86 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 64.97 |
| operating cycle | 149.05 |
| days of payables outstanding | 92.80 |
| cash conversion cycle | 56.25 |
| receivables turnover | 4.34 |
| payables turnover | 3.93 |
| inventory turnover | 5.62 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | 5.18 |
| long term debt to capitalization | 0.80 |
| total debt to capitalization | 0.84 |
| interest coverage | -1.18 |
| cash flow to debt ratio | -0.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.40 |
| cash per share | 22.04 |
| operating cash flow per share | -0.12 |
| free cash flow operating cash flow ratio | 3.35 |
| cash flow coverage ratios | -0.01 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -0.43 |
Frequently Asked Questions
When was the last time Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings?
Alnylam Pharmaceuticals, Inc. (ALNY) published its most recent earnings results on 31-07-2025.
What is Alnylam Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)'s trailing twelve months ROE is -274.21%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Alnylam Pharmaceuticals, Inc. (ALNY) currently has a ROA of -6.99%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALNY's net profit margin stand at?
ALNY reported a profit margin of -12.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALNY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.80 in the most recent quarter. The quick ratio stood at 2.75, with a Debt/Eq ratio of 5.18.